{
    "status": "ok",
    "totalResults": 5,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "NeuroMetrix Stock to Reverse Split on Wednesday, November 22nd (NASDAQ:NURO)",
            "description": "NeuroMetrix, Inc. (NASDAQ:NURO \u2013 Free Report)\u2019s stock is set to reverse split before the market opens on Wednesday, November 22nd. The 1-8 reverse split was announced on Monday, November 20th. The number of shares owned by shareholders will be adjusted after \u2026",
            "url": "https://www.etfdailynews.com/2023/11/20/neurometrix-stock-to-reverse-split-on-wednesday-november-22nd-nasdaqnuro/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/neurometrix-inc-logo.png&w=240&h=240&zc=2",
            "publishedAt": "2023-11-21T00:22:43Z",
            "content": "NeuroMetrix, Inc. (NASDAQ:NURO \u2013 Free Report)\u2019s stock is set to reverse split before the market opens on Wednesday, November 22nd. The 1-8 reverse split was announced on Monday, November 20th. The nu\u2026 [+3497 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "NeuroMetrix (NASDAQ:NURO) Receives New Coverage from Analysts at StockNews.com",
            "description": "StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO \u2013 Free Report) in a report released on Thursday. The firm issued a sell rating on the medical device company\u2019s stock. NeuroMetrix Stock Performance NASDAQ:NURO opened at $3.97 on Thursday. T\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/neurometrix-nasdaqnuro-receives-new-coverage-from-analysts-at-stocknews-com/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/neurometrix-inc-logo.png&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T06:52:43Z",
            "content": "StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO \u2013 Free Report) in a report released on Thursday. The firm issued a sell rating on the medical device company\u2019s stock.\r\nNeuroMetrix\u2026 [+2769 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "NeuroMetrix, Inc.",
            "title": "NeuroMetrix Announces One-for-Eight Reverse Stock Split",
            "description": "WOBURN, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc.\u00a0(NASDAQ: NURO) today announced that it will effect a one-for-eight reverse split of its common stock, effective at 5:00 pm\u00a0on\u00a0November 21, 2023\u00a0(the \u201cEffective Time\u201d). The shares underlying th\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/20/2783281/0/en/NeuroMetrix-Announces-One-for-Eight-Reverse-Stock-Split.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b5f3e442-f2d8-4ccc-a040-d4d97405f7c4",
            "publishedAt": "2023-11-20T14:00:00Z",
            "content": "WOBURN, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc.\u00a0(NASDAQ: NURO) today announced that it will effect a one-for-eight reverse split of its common stock, effective at 5:00 pm\u00a0on\u00a0Novemb\u2026 [+4614 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PIONEERING MARKETDIGITS CONSULTING AND ADVISORY PRIVATE LIMITED",
            "title": "Neurostimulation Market projected to reach USD 9.9 Billion by 2030, growing at a CAGR of 9.3% during the forecast period of 2023-2030 - pronounced by MarketDigits in its recent study",
            "description": "The Global Neurostimulation Market was valued USD 5.3 Billion in 2023 and projected to reach USD 9.9 Billion by 2030, growing at a CAGR of 9.3% during the forecast period of 2023-2030. The Global Neurostimulation Market was valued USD 5.3 Billion in 2023 and \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2784174/0/en/Neurostimulation-Market-projected-to-reach-USD-9-9-Billion-by-2030-growing-at-a-CAGR-of-9-3-during-the-forecast-period-of-2023-2030-pronounced-by-MarketDigits-in-its-recent-study.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/2960b872-d623-4363-9973-e881f17bf42f",
            "publishedAt": "2023-11-21T15:00:00Z",
            "content": "Richmond, Nov. 21, 2023 (GLOBE NEWSWIRE) -- According to a research report \"Neurostimulation Market\r\n, byType (Internal Neurostimulation (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve\u2026 [+11190 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DelveInsight Business Research LLP",
            "title": "Diabetic Nephropathy Market to Grow at a Substantial Growth Rate by 2032, Assesses DelveInsight |Key Players in the Market - Prokidney, Inversago, Palatin Technologies, Lexicon, Daiichi Sankyo, CSL Behring",
            "description": "Advances in disease mechanisms have yielded new diagnostic and therapeutic approaches, opening the way to more medical development. The diabetic nephropathy market is expected to show positive growth, mainly attributed to the increased diagnosed prevalence an\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/07/2775425/0/en/Diabetic-Nephropathy-Market-to-Grow-at-a-Substantial-Growth-Rate-by-2032-Assesses-DelveInsight-Key-Players-in-the-Market-Prokidney-Inversago-Palatin-Technologies-Lexicon-Daiichi-Sa.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
            "publishedAt": "2023-11-07T18:00:00Z",
            "content": "New York, USA, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Diabetic Nephropathy Market to Grow at a Substantial Growth Rate by 2032, Assesses DelveInsight |Key Players in the Market -\u00a0 Prokidney, Inversago, Pa\u2026 [+14247 chars]"
        }
    ]
}